Verification Parameters & Safeguards
Model: MythosGranular Screening Controls
Genomic Sequence Synthesis Review
Real-time cross-referencing against restricted viral & toxin accession bases.
Strict Biosecurity Toxin Screening
Enforce high-affinity ligand and dual-use virulence screening algorithms.
Chain-of-Custody Cryptographic Audit
Immutable transaction telemetry for all biological generation prompts.
LSVP Compliance Engine & Proof
Priority ClearanceCompliance Score
98.5
Threshold: 85.0 required for Mythos
Verification Status
Eligible for LSVP Priority Review
Meets Anthropic LSVP standard
Model Clearance
Mythos & Standard Claude Suite
High-capability biology authorized
Risk Mitigation Level
Maximum Safeguard Coverage
Full dual-use defense activated
| Threat Vector | Classification | Active Safeguard | Status |
|---|---|---|---|
| Select Agent Toxin Synthesis | Cat-1 Dual Use | Strict Biosecurity Screening | Mitigated |
| Restricted Genomic Sequences | CBRN Biosafety | Automated Accession Review | Active |
| Exfiltration & Prompt Obfuscation | Model Exploitation | Chain-of-Custody Audit | Enforced |
| Autonomous Synthesis Trigger | Execution Hazard | Mandatory Peer Review | Required |
Anthropic LSVP Protocol Architecture:
- Pre-Execution DNA/RNA Filtering: Prompts requesting oligonucleotides are cross-referenced with biological safety databases before model inference.
- Mythos Safe Harbor: Legitimate vaccine, antibody, and protein engineering researchers receive elevated capabilities with cryptographic provenance logging.
- Institutional Accountability: Lab credentials and Biosafety Officer signoffs are cryptographically bound to the API keys.